https://www.live-feeds.com/feed/personalized-mrna-cancer-vaccines-offer-new-hope-we-explainContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/personalized-mrna-cancer-vaccines-offer-new-hope-we-explainhttps://www.live-feeds.com/feed/personalized-mrna-cancer-vaccines-offer-new-hope-we-explain#u61028Tue, 08 Sep 2026 05:41:40 +0000Personalized mRNA cancer vaccines are entering a high-growth phase, highlighted by positive phase III results for Moderna and Merck in melanoma treatment. Moderna is expanding its strategy to include solo vaccines and in vivo CAR-T therapies, with clinical trials advancing in Korea. While the sector faces translational challenges, the development of these vaccines signals a shift in how mRNA technology is applied beyond infectious diseases, sparking a broader industry race to provide the necessary infrastructure and tools for vaccine production.Why it mattersmRNA technology gained global promi